ALXN2060

acoramidis · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALXN2060, covering 2024-12-16 to 2024-12-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CM [Phase 3]